4.8 Article

Release of anti-restenosis drugs from poly(ethylene oxide)-poly (DL-lactic-co-glycolic acid) nanoparticles

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 114, Issue 3, Pages 317-324

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2006.05.021

Keywords

restenosis; rapamycin; dexamethasone; biodegradable nanoparticles

Ask authors/readers for more resources

Dexamethasone- or rapamycin-loaded nanoparticles based on poly(ethylene oxide) and poly(DL-lactic-co-glycolic acid) block copolymers (PEO-PLGA) were prepared without additional stabilizer using the salting-out method. A fast release of drug in PBS (PH 7.4) at 37 degrees C resulting in 100% release within 5 It was observed for both drugs. The rate of drug release was substantially reduced by treating the particles with gelatin or albumin after drug loading, resulting in a linear drug release in time. It was shown that the rate of drug release is related to the amount of protein associated with the nanoparticles. After gelatin treatment of drug-loaded nanoparticles, sustained release of dexamethasone for 17 days and of rapamycin for 50 days could be achieved. (c) 2006 Elsevier B.V All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available